Transformando sistemas de salud con IA: Dr. Luis Eduardo Pino de Oxer en Arkangel AI

AI in oncology: Arkangel AI & Oxer on clinician-led, validated deployment in Latin America.

August 19, 2025by Jose Zea•3 min read

Transforming Health Systems with Arkangel AI and Oxer

This episode explores advancements in artificial intelligence in health with Arkangel AI and Oxer, highlighting their impact on clinical decision-making and digital transformation in oncology.

From Military Medicine to AI Transformation: Dr. Luis Eduardo Pino, Oxer & Arkangel AI

Host Laura Velasquez of Arkangel AI interviews Dr. Luis Eduardo Pino, CEO of Oxer, to reveal actionable strategies for advancing artificial intelligence in health across Latin America’s oncology landscape.

Summary

Laura Velasquez (Arkangel AI) and Dr. Luis Eduardo Pino (Oxer) discuss how artificial intelligence in health is reshaping medical workflows, care models, and decision-making in oncology and internal medicine. The episode provides practical insights for clinicians and innovators navigating digital transformation in healthcare today.

Episode at a Glance

Guests: Dr. Luis Eduardo Pino — CEO, Oxer
Topics: AI adoption in oncology, bridging clinical-technical gaps, digital health startups, workflow transformation, education for clinicians
Why it matters for artificial intelligence in health: Integrating robust AI models—grounded in deep clinical expertise—addresses inefficiencies and accelerates real-world patient impact beyond academic prototypes.

Overview

Artificial intelligence in health has moved from theoretical promise to on-the-ground transformation, especially in oncology. Arkangel AI (www.arkangel.ai) convenes Dr. Luis Eduardo Pino, CEO of Oxer, to examine how AI technology is influencing clinical care, research, and business models in the Latin American context. Dr. Pino’s military and medical background informs a practical approach to digital health transformation—spanning everything from predictive modeling to generative tools for patient support.

By tracing the evolution from manual, physician-driven processes to collaborative, AI-powered systems, this episode highlights why going beyond “innovation for innovation’s sake” is critical. Understanding the realities of local healthcare systems, Oxer’s strategy focuses on building, validating, and scaling AI solutions with direct clinician and patient input—ensuring these technologies deliver operational efficiency and measurable benefit at scale.

Key Takeaways

Bridging clinical and technical domains is essential to deliver AI models that serve frontline healthcare needs.
Iterative prototyping and user feedback accelerate relevant, scalable product development in digital health startups.
Comprehensive system understanding—beyond just clinical knowledge—is crucial before designing AI-powered solutions.
Validated deployment and structured clinician education are key to overcoming skepticism and implementation barriers.

Chapter Markers

[00:00] From battlefield medicine to AI: Dr. Pino’s journey
[05:12] Lessons from building Maya Health and digital MVPs
[14:37] Bridging sector gaps: Clinical, technical, and entrepreneurial skillsets
[22:09] Scaling AI: From research prototypes to hospital deployments

Notable Ideas

“To design effective solutions, you must first deeply understand the realities—bright and dark—of the health system.” — Dr. Luis Eduardo Pino, Oxer
“Artificial intelligence is a tool that can help humans become less intuitive and, ironically, more human.” — Dr. Luis Eduardo Pino, Oxer
“Clinical validation and education must go hand-in-hand to drive true adoption of artificial intelligence in health.” — Laura Velasquez, Arkangel AI

Why This Matters

For clinicians and health system leaders, artificial intelligence in health offers opportunities to streamline decision-making, reduce inefficiencies, and improve patient pathways—especially when digital tools are co-developed with deep clinical insight, as seen in Oxer’s oncology focus. Structured deployment and education are critical to bridge current gaps between research and real-world care, unlocking operational impact.

For medical affairs and digital health professionals, these insights clarify both barriers and best practices for integrating AI into complex environments. The approaches shared by Arkangel AI and Oxer emphasize not just technical sophistication but also regulatory, workflow, and adoption challenges unique to Latin America, guiding smarter investments and collaboration for lasting system improvements.

About Arkangel AI

Arkangel AI is dedicated to advancing artificial intelligence in health across Latin America, empowering clinicians, researchers, and health systems to harness AI for better outcomes. By prioritizing clinically validated, context-aware digital solutions and fostering cross-disciplinary education, Arkangel AI enables sustainable transformation in patient care and operational efficiency for the region.

FAQ

Q: How does artificial intelligence in health impact oncology workflows, according to the episode?

A: The episode details how AI can automate data analysis, support clinical decisions, and optimize resource allocation in oncology—especially when solutions are co-designed by companies like Oxer with direct clinician engagement.
Q: What unique barriers exist for adopting AI in health in Latin America?

A: Regulatory uncertainty, gaps between medical and data science expertise, and lack of clinical validation slow real-world adoption. Successes from Arkangel AI and Oxer’s experience show bridging these gaps is essential for scaling impact.